Pieris Pharmaceuticals Stock Price on December 3, 2024

PIRS Stock  USD 16.60  0.40  2.35%   
If you're considering investing in Pieris Stock, it is important to understand the factors that can impact its price. As of today, the current price of Pieris Pharmaceuticals stands at 16.60, as last reported on the 11th of December 2024, with the highest price reaching 16.93 and the lowest price hitting 16.24 during the day. Pieris Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.0108, which implies the firm had a -0.0108% return per unit of risk over the last 3 months. Pieris Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pieris Pharmaceuticals' insignificant Risk Adjusted Performance, coefficient of variation of (9,257), and Variance of 3.83 to confirm the risk estimate we provide.
  
Pieris Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0108

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsPIRS

Estimated Market Risk

 1.96
  actual daily
17
83% of assets are more volatile

Expected Return

 -0.02
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.01
  actual daily
0
Most of other assets perform better
Based on monthly moving average Pieris Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pieris Pharmaceuticals by adding Pieris Pharmaceuticals to a well-diversified portfolio.

Pieris Pharmaceuticals Valuation on December 3, 2024

It is possible to determine the worth of Pieris Pharmaceuticals on a given historical date. On December 3, 2024 Pieris was worth 16.73 at the beginning of the trading date compared to the closed value of 16.1. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Pieris Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Pieris Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Pieris Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Pieris Pharmaceuticals' related companies.
 Open High Low Close Volume
  16.40    17.00    16.31    16.43    34,503  
12/03/2024
  16.73    16.76    16.10    16.10    4,802  
  16.23    16.86    16.20    16.70    27,311  
Backtest Pieris Pharmaceuticals  |  Pieris Pharmaceuticals History  |  Pieris Pharmaceuticals Valuation   PreviousNext  
Open Value
16.73
16.1
Closing Value
22.60
Upside

Pieris Pharmaceuticals Trading Date Momentum on December 3, 2024

On December 04 2024 Pieris Pharmaceuticals was traded for  16.70  at the closing time. The top price for the day was 16.86  and the lowest listed price was  16.20 . The trading volume for the day was 27.3 K. The trading history from December 4, 2024 was a factor to the next trading day price appreciation. The trading delta at closing time against the next closing price was 3.73% . The trading delta at closing time against the current closing price is 4.66% .

Pieris Pharmaceuticals Fundamentals Correlations and Trends

By evaluating Pieris Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Pieris Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Pieris financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Pieris Pharmaceuticals Stock history

Pieris Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Pieris is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Pieris Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Pieris Pharmaceuticals stock prices may prove useful in developing a viable investing in Pieris Pharmaceuticals
Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs. Pieris Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Boston, Massachusetts. Pieris Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 124 people.

Pieris Pharmaceuticals Stock Technical Analysis

Pieris Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Pieris Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Pieris Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Pieris Pharmaceuticals Period Price Range

Low
December 11, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Pieris Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Pieris Pharmaceuticals December 11, 2024 Market Strength

Market strength indicators help investors to evaluate how Pieris Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pieris Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Pieris Pharmaceuticals stock market strength indicators, traders can identify Pieris Pharmaceuticals entry and exit signals to maximize returns

Pieris Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Pieris Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Pieris Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Pieris to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Pieris Stock Analysis

When running Pieris Pharmaceuticals' price analysis, check to measure Pieris Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pieris Pharmaceuticals is operating at the current time. Most of Pieris Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pieris Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pieris Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pieris Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.